Filter
2268
Filtered Results: 2268
Text search:
randomized
Featured
Recommendations
226
New Publications
387
Language
Document type
No document type
1182
Guidelines
464
Studies & Reports
398
Manuals
96
Fact sheets
49
Strategic & Response Plan
29
Training Material
26
Situation Updates
11
Infographics
7
Resource Platforms
5
Brochures
1
Countries / Regions
Global
94
India
93
South Africa
48
Kenya
43
Western and Central Europe
36
Russia
35
Brazil
34
Africa
29
Latin America and the Carribbean
28
Malawi
27
Uganda
26
Nepal
22
Ethiopia
22
Ukraine
20
Indonesia
19
Tanzania
18
Sierra Leone
17
Philippines
17
Eastern Europe
17
Zambia
17
Nigeria
16
Zimbabwe
16
Germany
15
Mozambique
14
Rwanda
13
Bangladesh
12
Colombia
11
Asia
11
Liberia
11
Ghana
10
Senegal
10
Burkina Faso
10
West and Central Africa
10
Argentina
10
South Sudan
10
Syria
9
Congo, Democratic Republic of
9
East and Southern Africa
9
Paraguay
8
Angola
8
Cameroon
7
USA
7
Middle East and North Africa
7
South–East Asia Region
7
Lesotho
6
Chile
6
Peru
6
Guinea
6
Eastern Europe and Central Asia
6
Namibia
6
Haiti
5
Bolivia
5
Yemen
5
Myanmar / Burma
5
China
4
Cambodia
4
Guinea-Bissau
4
Spain
4
Ecuador
4
Eswatini/ Swaziland
4
Thailand
3
Laos
3
Venezuela
3
Jordan
3
North America
3
Sudan
3
Iraq
3
Somalia
3
Benin
2
Kyrgyzstan
2
Burundi
2
Western Pacific Region
2
United Kingdom
2
Portugal
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Sri Lanka
2
Central African Republic
2
Mali
2
North Macedonia
1
Tajikistan
1
El Salvador
1
Turkey
1
Kazakhstan
1
Canada
1
Singapore
1
Estonia
1
Afghanistan
1
Qatar
1
Armenia
1
Belgium
1
France
1
Belarus
1
Israel
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Georgia
1
Botswana
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
549
Clinical Guidelines
340
Women & Child Health
168
Public Health
156
Key Resources
47
Capacity Building
21
Pharmacy & Technologies
10
Toolboxes
Mental Health
376
COVID-19
261
HIV
260
TB
161
NCDs
91
NTDs
78
Caregiver
77
Ebola
47
Planetary Health
40
Rapid Response
39
AMR
38
Disability
36
Pharmacy
26
Refugee
25
Conflict
24
Cholera
17
Global Health Education
16
Polio
9
Natural Hazards
7
Zika
7
Social Ethics
6
Health Financing Toolbox
5
Specific Hazards
1
Orientations provisoires
1er avril 2020
Les États Membres doivent améliorer les pratiques d’hygiène des mains de manière ambitieuse afin d’aider à prévenir la transmission du virus de la COVID-19 :
1. en fournissant un accès universel à des postes publics d’hygiène des mains et ...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Current evidence indicates that the COVID-19 virus is transmitted through respiratory droplets or contact. Contact transmission occurs when contaminated hands touch the mucosa of the mouth, nose, or eyes; the virus can also be transferred from one surface to another by contaminated hands, which fac...
Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-19, HIV và thuốc antiretrovirals (ARVs)
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
L’ hygiène des mains est la mesure la plus efficace pour réduire la propagation des infections dans le cadre de stratégies multimodales, y compris l’accès à des fournitures appropriées. Les présentes orientations concernent donc tous les pays ...
COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung prob...
It is intended for use among clinicians taking care of moderate to severe COVID-19 cases.
The COVID-19 outbreak has brought with it the need for improved critical care for patients who develop severe disease. The majority of COVID-19 patients present with mild to moderate illness, 15% develop sever...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
This document draws on scientific evidence from the COVID-19 pandemic and from prior public health research on behaviour change, with the purpose of empowering African Union Member States to promote widespread adoption of masks in the general population. This document complements existing Africa CDC...
10 December 2020
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
